Technology News and Research

RSS

MEDecision launches InFrame collaborative HIE service

MEDecision, Inc., a leading provider of collaborative healthcare management solutions, today introduced the next generation of its healthcare management technology with the launch of InFrame™, a collaborative health information exchange (HIE) service that enables care delivery organizations to share clinical data — including diagnostic-quality medical images — among themselves and with patients to more effectively drive business and comply with meaningful use criteria.

17 Feb 2010

ITS secures £8.65M Series-A equity funding round extension to fund synthetic flu vaccine study

Immune Targeting Systems (ITS) Limited (“ITS”), one of the leading developers of synthetic vaccines for mutating viruses, today announced it had secured a Series-A equity funding round extension for £8.65m which brings the total Series A financing to £13.15m. The company’s key investors HealthCap (Sweden), London Technology Fund (UK), Novartis Venture Fund (US & Basel) and Truffle Capital (France) are all participating. The round will be kept open until mid-2010 for new potential investors to invest.

17 Feb 2010

Bluegiga Technologies introduces Bluegiga eHealth Access Point for health and medical applications

Bluegiga Technologies announced today the availability of their new Bluegiga eHealth Access Point based on Bluetooth Health Device Profile (HDP). The new technology can be utilised in various health and medical applications.

17 Feb 2010

Medical journal finds divide between doctors and patients on new mammogram recommendations

News outlets explore confusion about cancer screening guidelines and questions raised about the effects of high tech procedures on health care costs and quality.

17 Feb 2010

Iowa State University researchers awarded 30 ARRA grants worth $16.38M

Iowa State University researchers have so far won 30 grants worth a total $16.38 million from federal agencies awarding money from the American Recovery and Reinvestment Act (ARRA).

17 Feb 2010

Shared Health partners with MEDai to provide HIE platform to the state of Tennessee

Shared Health, Inc., Tennessee's largest public/private health information exchange (HIE) has partnered with MEDai, an Elsevier company, to provide a rich, interoperable, clinically relevant HIE platform to the state of Tennessee. This partnership delivers best in class solutions and technologies that support clinical excellence and operating efficiencies.

17 Feb 2010

In naming Islamic Conference Envoy, Obama highlights global health, food security efforts

During a video address to the 7th U.S.-Islamic World Forum meeting in Doha, Qatar, on Saturday, President Barack Obama appointed Rashad Hussain, deputy associate White House counsel, to serve as Special Envoy to the Organization of the Islamic Conference (OIC), the Associated Press reports.

17 Feb 2010

GeneNews granted second U.S. patent for Sentinel Principle technology

GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted a second U.S. patent for its core platform technology, the Sentinel Principle(R). U.S. Patent # 7,662,558, entitled "Method of profiling gene expression in a human subject."

17 Feb 2010

Utah dentists use Apex OneTouch solution to process patient insurance claims for reimbursement

Apex EDI, one of the nation’s leading e-claims reimbursement companies for dental and medical professionals, has served more than 1,100 dentists in Utah with leading-edge technology solutions focused on streamlined and efficient claims processing. More than 50 percent of all dentists in Utah actively use the Apex electronic claims solution to process patient insurance claims for reimbursement -- more than all other clearinghouses combined.

17 Feb 2010

Exagen Diagnostics, EndoChoice announce agreement for promoting diagnostic services to U.S. gastroenterologists

Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, today announced an exclusive sales and marketing agreement with EndoChoice, Inc. to promote its diagnostic services to gastroenterologists throughout the United States.

17 Feb 2010

Calypso real-time tumor tracking system usage during IMRT for prostate cancer reduces rectal/urinary side effects

Calypso Medical Technologies, Inc., a developer of targeting technology used for accurate, precise real-time tracking of tumor targets, today announced the online publication of a clinical study in Urology (The GOLD JOURNAL). The prospective, multi-site study, entitled, “Assessing the Impact of Margin Reduction (AIM),” is the first outcomes-based study to evaluate the quality of life of high-dose intensity-modulated radiotherapy (IMRT) to the prostate with tightly contoured treatment technically described as “reduced treatment margins.”

17 Feb 2010

Energetiq Technology launches new LDLS light sources for advanced technology applications

Energetiq Technology, Inc., a developer and manufacturer of specialized light sources for advanced technology applications, will introduce its Laser-Driven Light Source (LDLS™) product family to the largest gathering of biophysicists in the world at the Biophysical Society 54th Annual Meeting in San Francisco, February 21-23, 2010.

17 Feb 2010

Scienta Health signs agreement with Partners HealthCare to provide advanced acute care to its clients

Scienta Health today announced that it has entered into an agreement with Boston-based Partners HealthCare, the leading academic medical network in the U.S. Partners HealthCare includes major teaching hospitals affiliated with Harvard Medical School: the Massachusetts General Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, McLean Hospital, a treatment and research leader in mental illness, chemical dependency and learning disabilities; and Spaulding Rehabilitation Hospital, a top-ranked rehabilitation facility.

17 Feb 2010

ViewRay earns NorTech Innovation Award for advancements in cancer radiation therapy technology

ViewRay, Inc., a privately held medical device company, has earned a NorTech Innovation Award for its advancements in radiation therapy technology for the treatment of cancer. ViewRay was honored for its unique combination of medical imaging and radiotherapy, which is designed to improve the effectiveness of cancer treatments. Radiation therapy is used to treat nearly two-thirds of today's cancer patients.

17 Feb 2010

Researchers adopt new technique to inhibit cancer growth

One of the difficulties of fighting cancer is that drugs often hit other non-cancerous cells, causing patients to get sick. But what if researchers could sneak cancer-fighting particles into just the cancer cells?

17 Feb 2010

MIT announces the publication of major research report of its symbol MDLH

Medical International Technology Inc. www.mitneedlefree.com is pleased to announce the publication of a major research report of its symbol MDLH by Grass Roots Research and Distribution, Inc.

17 Feb 2010

New DNA: Dynamic NextGen Analytics platform now available from IntegriChain

IntegriChain, Inc., a commercial insight provider supporting the pharmaceutical industry, announces the launch of its new DNA: Dynamic NextGen Analytics™ (DNA) platform.

17 Feb 2010

National symposium aims to attract more women for a rewarding career in surgery

While interviewing for postgraduate residency positions soon after giving birth to her third child, Dr. Sharona Ross recalls, she was very hesitant to bring up her infant and two small children at home. She thought it would hurt her chances for a career in surgery.

17 Feb 2010

Sequenom CMM launches SensiGene Fetal Sex Determination test

Sequenom, Inc. today announced the launch of the SensiGene™ Fetal(XY) (Fetal Sex Determination) test by Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM). This is the company's second laboratory developed test powered by its SEQureDx™ technology.

17 Feb 2010

Embera NeuroTherapeutics establishes clinical development partnership for its cocaine dependence program

Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for drug dependence, smoking cessation and obesity, announced today that the company has retained Exponential Pharma Ventures LLC to assist in establishing a clinical development partnership for its cocaine dependence program with a fully integrated pharmaceutical company.

17 Feb 2010

Technology News and Research

MEDecision launches InFrame collaborative HIE service

ITS secures £8.65M Series-A equity funding round extension to fund synthetic flu vaccine study

Bluegiga Technologies introduces Bluegiga eHealth Access Point for health and medical applications

Medical journal finds divide between doctors and patients on new mammogram recommendations

Iowa State University researchers awarded 30 ARRA grants worth $16.38M

Shared Health partners with MEDai to provide HIE platform to the state of Tennessee

In naming Islamic Conference Envoy, Obama highlights global health, food security efforts

GeneNews granted second U.S. patent for Sentinel Principle technology

Utah dentists use Apex OneTouch solution to process patient insurance claims for reimbursement

Exagen Diagnostics, EndoChoice announce agreement for promoting diagnostic services to U.S. gastroenterologists

Calypso real-time tumor tracking system usage during IMRT for prostate cancer reduces rectal/urinary side effects

Energetiq Technology launches new LDLS light sources for advanced technology applications

Scienta Health signs agreement with Partners HealthCare to provide advanced acute care to its clients

ViewRay earns NorTech Innovation Award for advancements in cancer radiation therapy technology

Researchers adopt new technique to inhibit cancer growth

MIT announces the publication of major research report of its symbol MDLH

New DNA: Dynamic NextGen Analytics platform now available from IntegriChain

National symposium aims to attract more women for a rewarding career in surgery

Sequenom CMM launches SensiGene Fetal Sex Determination test

Embera NeuroTherapeutics establishes clinical development partnership for its cocaine dependence program

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News